California State Teachers Retirement System (CalSTRS)
BTAI icon

California State Teachers Retirement System (CalSTRS)’s BioXcel Therapeutics BTAI Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-149
Closed -$6.7K – 3103
2024
Q1 		$6.7K Sell
149
-60
-29% -$2.86K ﹤0.01% 2972
2023
Q4 		$9.85K Sell
209
-1,197
-85% -$66.5K ﹤0.01% 3005
2023
Q3 		$56.9K Sell
1,406
-109
-7% -$11K ﹤0.01% 2668
2023
Q2 		$161K Sell
1,515
-6
-0.4% -$2K ﹤0.01% 2570
2023
Q1 		$454K Sell
1,521
-21
-1% -$8.97K ﹤0.01% 2348
2022
Q4 		$530K Buy
1,542
+17
+1% +$4.11K ﹤0.01% 2313
2022
Q3 		$288K Sell
1,525
-5
-0.3% -$1.16K ﹤0.01% 2543
2022
Q2 		$323K Buy
1,530
+14
+0.9% +$2.94K ﹤0.01% 2547
2022
Q1 		$507K Sell
1,516
-100
-6% -$29K ﹤0.01% 2394
2021
Q4 		$526K Buy
1,616
+41
+3% +$17.6K ﹤0.01% 2491
2021
Q3 		$765K Buy
1,575
+258
+20% +$113K ﹤0.01% 2291
2021
Q2 		$612K Buy
1,317
+113
+9% +$61.6K ﹤0.01% 2534
2021
Q1 		$832K Sell
1,204
-4
-0.3% -$3.22K ﹤0.01% 2258
2020
Q4 		$893K Buy
1,208
+99
+9% +$77.1K ﹤0.01% 2108
2020
Q3 		$769K Buy
1,109
+112
+11% +$84.1K ﹤0.01% 2020
2020
Q2 		$846K Buy
997
+367
+58% +$239K ﹤0.01% 1941
2020
Q1 		$225K Buy
630
+50
+9% +$18K ﹤0.01% 2497
2019
Q4 		$136K Hold
580
– – ﹤0.01% 2878
2019
Q3 		$65K Hold
580
– – ﹤0.01% 2971
2019
Q2 		$102K Buy
+580
New +$98.2K ﹤0.01% 2979

Other funds holding BTAI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s BTAI Position: Q2 2024 in Review

California State Teachers Retirement System (CalSTRS) sold out of BioXcel Therapeutics (BTAI) in Q2 2024, closing a stake of 149 shares — an estimated $6.7K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in BTAI in Q2 2019 and held it in 20 quarters. The position peaked at $893K in Q4 2020. 74 funds tracked by Wall St. Rank hold BTAI as of Q2 2024.

  • California State Teachers Retirement System (CalSTRS) reported no remaining BioXcel Therapeutics position as of Q2 2024 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 149 BioXcel Therapeutics shares in Q2 2024, an estimated $6.7K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in BioXcel Therapeutics in Q2 2019 and held it in 20 quarters.
  • California State Teachers Retirement System (CalSTRS)'s BioXcel Therapeutics position peaked at $893K in Q4 2020.
  • 74 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q2 2024.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2024, filed 14 Aug 2024.